Victor Babes Hospital Bucharest

What Victor Babes Hospital Bucharest does

Spitalul Clinic de Boli Infecțioase și Tropicale Dr. Victor Babeș is a public clinical hospital in Bucharest, Romania, operating under the Romanian Ministry of Health as a national referral center for infectious diseases, tropical medicine, HIV/AIDS, tuberculosis, and viral hepatitis. The institution operates across multiple pavilions (A, B1–B4, Casa Doru) on the Șoseaua Mihai Bravu campus, comprising six clinical sections for adult and pediatric infectious diseases, a 40-bed dermatovenerology section, an 82-bed pneumology section (including 12 TB beds and 10 respiratory rehabilitation beds), and a specialized ICU — totaling 463 inpatient beds supported by approximately 600+ staff. Diagnostic infrastructure is anchored by 10 specialized laboratories accredited to SR EN 15189:2023 for clinical microbiology and parasitology, featuring MALDI-TOF mass spectrometry, GeneXpert, BioFire FilmArray syndromic PCR panels, and participation in the European Antimicrobial Resistance Surveillance Network (EARS-Net). The hospital also operates a Research Nucleus conducting Phase II–IV clinical trials and a paid Travel Medicine Cabinet offering tropical disease prophylaxis and vaccination.

The hospital's revenue model is a hybrid of public reimbursement and fee-for-service. The dominant revenue stream flows through Casa de Asigurări de Sănătate a Municipiului București (CAS MB) under Romania's national health insurance framework, supplemented by direct government budget allocations for national health programs (HIV/AIDS, TB, hepatitis) and PNRR (National Recovery and Resilience Plan) funding for digital infrastructure modernization (Project nr. 1719/208/I3.3/12.03.2024). Secondary fee-for-service revenue is generated from uninsured hospitalizations (200 lei/day), specialty consultations (200 lei), a travel medicine cabinet (100–350 lei per consultation, with vaccine fees ranging 98–350 lei per dose), laboratory tests (10–450 lei), radiology and CT imaging (100–1,000 lei), and dermatology procedures (15–300 lei). Patient acquisition occurs through family physician referral letters with national health cards, emergency admission, and online appointment scheduling (programari.spitalulbabes.ro). As a public entity, the institution does not engage in commercial marketing; communications are managed through the official website, a designated spokesperson (Dr. Stefan Dragos Lazar), and the Romanian Ministry of Health's patient feedback platform.

Name

Victor Babes Hospital Bucharest

Legal name

Spitalul Dr. Victor Babeș

Website

https://spitalulbabes.ro

Company type

Public

Operating status

Operating

Headcount range

51–100 employees

Short description

Victor Babeș Hospital Bucharest is a public clinical hospital under the Romanian Ministry of Health, operating 463 beds across infectious disease, pneumology, and dermatology sections, serving as a national referral center for HIV/AIDS, tuberculosis, and tropical diseases with 10 accredited laboratories and a paid travel medicine clinic.

Ownership category

akta.pro rank

Product category

Specialty Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Medical and Diagnostic Laboratories (62151), Other Ambulatory Health Care Services (6219)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Medical Laboratories (8071)

akta.pro primary industry

Inpatient Infectious Disease & Isolation Specialty Hospitals (HLAFAHAI)

akta.pro secondary industry

Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

Keywords

• Infectious disease treatment
• Tropical medicine services
• Clinical laboratory diagnostics
• Epidemiology research
• Hospital inpatient care

Headquarters

HQ city

Bucharest

HQ country

Romania

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. National Health Insurance (CAS MB): The hospital's primary revenue stream is through Romania's national health insurance system. Services for insured patients are covered by Casa de Asigurări de Sănătate a Municipiului București (CAS MB), including hospitalizations, consultations, and investigations, provided patients present a referral letter from their family doctor and national health card. The hospital participates in national health programs for HIV/AIDS (Programul Național de Supraveghere și Control al Infecției HIV/SIDA), tuberculosis (Programul Național de Supraveghere și Control al Tuberculozei), and viral hepatitis.
2. Out-of-Pocket / Fee-for-Service: The hospital generates revenue from fee-for-service medical services paid directly by patients. This includes the Tropical Diseases and Travel Medicine Cabinet (a paid clinic), dermatology consultations and minor procedures, laboratory tests at published tariff rates, radiology and imaging services, and hospitalization for uninsured patients at 200 lei/day. Special rooms (reserved rooms 4-6 and 12-14 in Section IV) are available at 250 lei/day.
3. Government Budget / Subsidies: As a public clinical hospital under the Romanian Ministry of Health, the institution receives annual government budget allocations for operational expenses. Published annual budgets (2021–2025) are available on the website under the Financial section.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels4 records

Core offering

Victor Babeș Hospital Bucharest provides inpatient and outpatient clinical care focused on the diagnosis, treatment, and monitoring of infectious and tropical diseases. It operates 463 hospital beds across multiple clinical sections, ten specialized laboratories, and a research nucleus supporting epidemiology, clinical trials, and public-health surveillance for referred and self-presenting patients.

Product overview

Victor Babeș Hospital Bucharest operates as a specialized clinical hospital for infectious and tropical diseases, offering a comprehensive range of medical services through a platform-plus-modules architecture. The core offering consists of six clinical sections for infectious diseases (I-VI) and specialized departments including Pneumology, Dermatovenerology, and an Intensive Care Unit, supported by specialized outpatient cabinets for tropical medicine and hepatitis treatment. The hospital's diagnostic infrastructure comprises ten fully-equipped laboratories (Biochemistry, Hematology, Clinical Microbiology, Serology, Virology/Immunology/Molecular Biology, Parasitology, Pathology, Radiology, and Blood Transfusion) along with specialized compartments for respiratory endoscopy, functional exploration, and rehabilitation. Public health services include epidemiology surveillance, early warning systems, and healthcare-associated infection control. The facility also operates a scientific research nucleus conducting clinical trials and national/international research projects. The hospital provides both inpatient (approximately 483 beds across all sections) and outpatient services, with additional paid services including travel medicine consultations and vaccinations.

Differentiator

Problem solved

Functional benefit

Products and services

• Inpatient infectious disease treatment Comprehensive inpatient care across multiple clinical sections for patients with infectious and tropical diseases, delivered on a 463-bed campus under Romania's Ministry of Health.
• Outpatient infectious disease consultations Specialty outpatient clinic services for diagnosis, treatment follow-up, and monitoring of infectious and tropical disease patients at the hospital campus.
• Specialized clinical laboratory diagnostics Diagnostic testing services delivered through ten on-site specialized laboratories supporting infectious and tropical disease identification for inpatients, outpatients, and external referrals.
• Medical imaging services Medical imaging infrastructure supporting inpatient and outpatient diagnostics for infectious and tropical disease patients at the hospital campus.
• Epidemiology and public-health surveillance services Dedicated epidemiology compartment providing disease surveillance, outbreak monitoring, and public-health reporting functions tied to the hospital's infectious disease caseload.
• Clinical research and trials Research nucleus conducting clinical trials and translational research in infectious and tropical diseases, supporting both internal investigators and external collaborators.
• Self-pay hospital services Direct-payment hospital and laboratory services offered to patients outside the public insurance scheme through the hospital's self-pay billing channel.

Quantifiable outcome

• 463 inpatient beds across 6 clinical sections plus ICU and auxiliary units
• +4 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature11 records

Partnerships

Five partnerships are on record, tiered core and minor.

• EARS-Net (European Antimicrobial Resistance Surveillance Network)coreOthersThe Clinical Microbiology Laboratory is an active member of the European Antimicrobial Resistance Surveillance Network (EARS-Net), participating annually in external quality control programs organized by EARSS. The laboratory contributes Romanian data on antimicrobial resistance patterns to the European database, enabling cross-border surveillance and informing empirical antibiotic therapy guidelines.
• COMBACTE Consortium (COMBACTE-CARE, COMBACTE-NET, COMBACTE-MAGNET, COMBACTE-ECRTB)minorStrategic or Co-development PartnerThe hospital's Clinical Microbiology Laboratory participated in multiple COMBACTE studies: EURECA (observational study on carbapenemase-producing bacteria in Eastern Europe, started 2016), ANTICIPATE (observational study on Clostridioides difficile prevalence, 2016-2017), COMBACTE CDI (European epidemiology of C. difficile, 2017), and REVISIT (Phase III clinical trial on Aztreonam/Avibactam for Gram-negative resistant infections). These are part of the IMI (Innovative Medicines Initiative) funded public-private partnership between EFPIA companies and the European Commission.
• Casa de Asigurări de Sănătate a Municipiului București (CAS MB)coreOthersThe primary public health insurer contracting the hospital for healthcare services provided to insured Bucharest residents. Services covered include hospitalizations, specialist consultations, diagnostic investigations, and treatments under national health programs. The hospital operates under the Contract Cadru regulated by the National Health Insurance House (CNAS).
• National Research Projects (Capacities – Research Infrastructures / FP7 / UEFISCDI)minorStrategic or Co-development PartnerThe Clinical Microbiology Laboratory participated in: (1) FP7 Capacities – Research Infrastructures 'European Research Infrastructure on Highly Pathogenic Agents' (2010); (2) National project UEFISCDI 140/PED/2017-2018 'AntarcticPharm' - Antarctic bacteria against human pathogens: searching for new antibacterial compounds; (3) EARSS external quality control programs annually. These projects enable the laboratory to access cutting-edge research methodologies and international collaborations.
• Association for the Development of Victor Babeș Clinical Hospital (Asociația de Dezvoltare a Spitalului Clinic Dr. Victor Babeș)minorOthersA dedicated hospital development association established to support the hospital's mission, facilitate external collaborations, and support fundraising for hospital improvements and projects beyond government budget allocations.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Hospital for Tropical Diseases (University College London Hospitals NHS Foundation Trust): The UK's primary specialist hospital for tropical and infectious diseases, directly comparable in scope: inpatient infectious disease beds, travel medicine clinic, and HIV/hepatitis outpatient services. Aligns with Victor Babeș on tropical medicine, HIV care, and integrated laboratory diagnostics.
• Cantacuzino National Institute of Research-Development for Microbiology and Immunology: Romanian national reference laboratory for microbiology and immunology. While primarily a research and reference lab rather than a hospital, it is the most directly comparable national-level infectious disease organization operating alongside Victor Babeș in the same regulatory and clinical ecosystem.
• Bernhard Nocht Institute for Tropical Medicine: German center for tropical medicine and infectious diseases, combining inpatient care, tropical medicine outpatient services, advanced diagnostic laboratories, and EARS-Net surveillance participation. Highly comparable mix of clinical, laboratory, and surveillance functions.
• Prof. Dr. Matei Balș National Institute of Infectious Diseases: Romania's other flagship infectious disease hospital, also located in Bucharest. Directly competes for national infectious disease referrals, HIV/AIDS patients, and tropical medicine cases. Comparable multi-pavilion scale, similar CAS MB contracting model, and overlapping research activity make it the closest peer.

Broad incumbents

• Charité – Universitätsmedizin Berlin: Europe's largest university hospital with a dedicated Department of Infectious Diseases and Respiratory Medicine. Comparable as a broad incumbent operating infectious disease, pneumology, and tropical medicine services alongside a much wider clinical and research portfolio.
• Karolinska University Hospital: Stockholm's academic hospital with a strong infectious disease and tropical medicine unit. Comparable in operating advanced molecular diagnostics, contributing to EU surveillance networks, and combining clinical infectious disease care with research activities, but as part of a much larger general hospital.
• Hospital Clinic de Barcelona: Spanish tertiary academic hospital with a leading infectious disease department and tropical medicine unit (Drassanes-Vall d'Hebron). Comparable in combining HIV, hepatitis, and tropical disease care with research and advanced diagnostics, but embedded in a broader university hospital system.
• Hôpital Bichat-Claude Bernard (AP-HP): Major Paris university hospital with a leading infectious disease department, tropical medicine unit, and AMR surveillance activities. Comparable as a large European academic center specializing in infectious diseases, but operating within a much broader multi-specialty portfolio.

Regional players

• Colentina Clinical Hospital: Other large Bucharest public hospital with overlapping dermatovenereology and internal medicine functions. Comparable as a public Romanian hospital serving Bucharest through CAS MB contracting, but with a much broader multi-specialty focus and no dedicated tropical medicine mandate.
• Institutul Național de Boli Infecțioase 'Prof. Dr. Matei Balș' – secții externe și centre regionale: Regional infectious disease centers affiliated with Romania's national infectious disease network. Comparable as national-program participants delivering HIV/AIDS, TB, and hepatitis care, but operating at smaller scale outside Bucharest and not offering tropical medicine.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/victor-babes-hospital-bucharest

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Victor Babes Hospital Bucharest